Dolby Laboratories Inc. (NYSE: DLB) reported Q3 GAAP EPS of $0.38, and non-GAAP EPS of $0.52, versus analyst estimate of $0.27. Revenue for the quarter came in at $223.4 million versus the consensus estimate of $210.23 million.

Dolby Laboratories Inc. sees Q4 2014 GAAP EPS of $0.28-$0.33 and no-GAAP $0.43-$0.48, versus the consensus of $0.34. Dolby Laboratories Inc. sees Q4 2014 revenue of $210-220 million, versus the consensus of $223.1 million.

Dolby Laboratories Inc. sees FY2014 revenue of $945-955 million, versus the consensus of $941.5 million.

For earnings history and earnings-related data on Dolby Laboratories Inc. (DLB) click here.